SCHEMBL12331095

SCHEMBL12331095

COCC[C@@H](C)[C@H]1C[C@H](O)[C@@]2(C)C3CCC4C(C)(C)C(O[C@H](OCC=O)C(O)C=O)CCC45CC35CCC12C

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.37
▸ HSD11B2 P80365 1/20 0.37
▸ ACLY P53396 2/20 0.37
▸ ACACA Q13085 2/20 0.37
▸ PTPN11 Q06124 1/20 0.35
▸ APP P05067 7/20 0.33
▸ CYP3A4 P08684 3/20 0.33
▸ PSEN1 P49768 6/20 0.31
▸ PSEN2 P49810 6/20 0.31
▸ APH1B Q8WW43 6/20 0.31
▸ NCSTN Q92542 6/20 0.31
▸ APH1A Q96BI3 6/20 0.31
▸ PSENEN Q9NZ42 6/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12332241 0.77 PSEN1 (0.49) HSD11B1HSD11B2ACLYACACAPTPN11
SCHEMBL12331892 0.75 PSEN1 (0.49) HSD11B1HSD11B2ACLYACACAPTPN11
SCHEMBL12331275 0.74 PSEN1 (0.51) HSD11B1HSD11B2ACLYACACAAPP
SCHEMBL14773157 0.73 ACLY (0.33) HSD11B1HSD11B2ACLYACACA
SCHEMBL14768574 0.73 ACLY (0.33) HSD11B1HSD11B2ACLYACACA
SCHEMBL14768521 0.72 APP (0.53) APPCYP3A4
SCHEMBL14773587 0.72 PSEN1 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14772438 0.71 PSEN1 (0.42) HSD11B1HSD11B2ACLYACACAAPP
SCHEMBL14753006 0.71 PTPN11 (0.48) HSD11B1HSD11B2ACLYACACAPTPN11
SCHEMBL14773069 0.69 APP (0.57) APPCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011109657-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC. (US) 2011-09-09 — — WO disclosed
Send feedback